Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.3K Sell
663
-7,263
-92% -$325K ﹤0.01% 1553
2026
Q1
$382K Sell
7,926
-2,251
-22% -$105K ﹤0.01% 566
2025
Q4
$493K Sell
10,177
-2,243
-18% -$111K 0.01% 485
2025
Q3
$586K Sell
12,420
-4,112
-25% -$198K 0.01% 441
2025
Q2
$799K Sell
16,532
-274
-2% -$14K 0.01% 332
2025
Q1
$932K Buy
16,806
+4,708
+39% +$255K 0.01% 257
2024
Q4
$583K Sell
12,098
-5,948
-33% -$302K 0.01% 336
2024
Q3
$876K Buy
18,046
+4,346
+32% +$235K 0.01% 301
2024
Q2
$666K Buy
13,700
+4,266
+45% +$206K 0.01% 297
2024
Q1
$458K Buy
9,434
+2,467
+35% +$120K 0.01% 286
2023
Q4
$374K Buy
6,967
+1,068
+18% +$52.2K 0.01% 298
2023
Q3
$318K Buy
5,899
+4,159
+239% +$222K ﹤0.01% 332
2023
Q2
$95K Sell
1,740
-11,035
-86% -$594K ﹤0.01% 519
2023
Q1
$619K Buy
12,775
+6,513
+104% +$317K 0.01% 251
2022
Q4
$239K Buy
6,262
+3,464
+124% +$152K ﹤0.01% 404
2022
Q3
$140K Buy
2,798
+2,134
+321% +$95.1K ﹤0.01% 421
2022
Q2
$34K Buy
+664
New +$35.2K ﹤0.01% 802

Other funds holding SNY

Blue Trust Inc's SNY Position: Q2 2026 in Review

Blue Trust Inc reduced its Sanofi (SNY) stake by 92% in Q2 2026, selling an estimated $325K and leaving 663 shares worth $28.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1553.

Blue Trust Inc first reported a position in SNY in Q2 2022 and has held it in 17 quarters since. The position peaked at $932K in Q1 2025. 128 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Blue Trust Inc held 663 shares of Sanofi worth $28.3K as of Q2 2026.
  • Blue Trust Inc sold 7,263 Sanofi shares in Q2 2026, an estimated $325K.
  • Sanofi made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1553 holding.
  • Blue Trust Inc first reported a position in Sanofi in Q2 2022 and has held it in 17 quarters since.
  • Blue Trust Inc's Sanofi position peaked at $932K in Q1 2025.
  • 128 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.